Vosoritide is a synthetic analogue of C-type natriuretic peptide (CNP) used as a therapeutic agent to stimulate endochondral bone growth in pediatric patients diagnosed with achondroplasia. The analytical… Read more


















Vosoritide is a synthetic analogue of C-type natriuretic peptide (CNP) used as a therapeutic agent to stimulate endochondral bone growth in pediatric patients diagnosed with achondroplasia. The analytical materials provided in this category support pharmaceutical research and manufacturing by offering high-quality reference standards essential for rigorous quality control. These compounds are critical for accurate impurity profiling, allowing laboratories to identify and quantify specific degradants, such as oxidized species, acetylated forms, or D-amino acid substitutions, that may arise during synthesis or storage. Furthermore, stable isotope labelled compounds, such as deuterium-labelled variants, serve as vital internal standards in liquid chromatography-mass spectrometry bioanalytical assays. Utilizing these validated materials ensures compliance with regulatory requirements for method validation and helps maintain the integrity of analytical testing throughout the drug development lifecycle for this peptide-based therapy.